This document is page 96 of a financial research report titled 'Cowen Collaborative Insights' dated February 25, 2019. It contains 'Figure 136 Cannabis Comp Table,' an appendix listing market data and valuations for various cannabis-related companies such as Aphria Inc, Aurora Cannabis Inc, and Level Brands Inc. The document bears a 'HOUSE_OVERSIGHT_024912' stamp, indicating it was part of a document production to the House Oversight Committee, likely obtained from the files of Michael Cella at Cowen.
| Name | Role | Context |
|---|---|---|
| Michael Cella | Recipient/Employee |
Listed in the right margin watermark: 'This report is intended for michael.cella@cowen.com'
|
| Name | Type | Context |
|---|---|---|
| Cowen |
Investment bank issuing the report
|
|
| Thomson Reuters |
Cited in footer
|
|
| US House Committee on Oversight and Reform |
Implied by the stamp 'HOUSE_OVERSIGHT_024912'
|
|
| 1933 Industries Inc |
Listed in comp table
|
|
| Aphria Inc |
Listed in comp table
|
|
| Aurora Cannabis Inc |
Listed in comp table
|
|
| Charlotte's Web Holdings Inc |
Listed in comp table
|
|
| Cronos Group Inc |
Listed in comp table
|
|
| Curaleaf Holdings Inc |
Listed in comp table
|
|
| CV Sciences Inc |
Listed in comp table
|
|
| Elixinol Global Ltd |
Listed in comp table
|
|
| Emblem Corp |
Listed in comp table
|
|
| Emerald Health Therapeutics Inc |
Listed in comp table
|
|
| Green Organic Dutchman Holdings Ltd |
Listed in comp table
|
|
| Green Thumb Industries Inc |
Listed in comp table
|
|
| Khiron Life Sciences Corp |
Listed in comp table
|
|
| Level Brands Inc |
Listed in comp table
|
|
| Neptune Wellness Solutions Inc |
Listed in comp table
|
|
| OrganiGram Holdings Inc |
Listed in comp table
|
|
| Canopy Growth Corp |
Listed in comp table
|
|
| KushCo Holdings Inc |
Listed in comp table
|
|
| Tilray Inc |
Listed in comp table
|
|
| Turning Point Brands Inc |
Listed in comp table
|
"This report is intended for michael.cella@cowen.com. Unauthorized redistribution of this report is prohibited."Source
Complete text extracted from the document (3,306 characters)
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document